RM5 should not be a big resistance, 5.10-5.11 is. After 5.11 will be 5.40 based on TA as follows: (TA technical analysis-Genting Berhad need confirmed breakout above the RM5.10 recent high to extend recovery towards RM5.40, with next hurdles at the 123.6%FP (RM5.60) and 138.2%FP (RM5.95) ahead, while the rising 100-day ma (RM4.56) provide uptrend support. Genting Malaysia will require decisive breakout above the 19/3/21 high (RM2.87) to fuel uptrend momentum towards RM3.00, with tougher hurdles at 123.6%FP (RM3.15) and 138.2%FP (RM3.33) going forward, while uptrend support also come from the rising 100-day ma (RM2.62).)
Everyone said ..a recession or market correction was imminent... but ang moh Jones has never been more bullish, soaring to new height and breaking record almost daily... why worry? Go ..go GenB
Still washing plate and slowly accumulating before next move. Time Will come and be patient. Sooner or later TauRX going to approve and we will be laughing all the way to the bank.
@Michael_chan2022. That is old new. Genting will wait till listing because Taurx medicine can benefit AD patients. Taurx has completed test last year and published result this year at World Congress. In the mean time, i believe they have prepared for commercial production of the drug. Once FDA approved the drug, marketing of the drug can be carried out. IPO listing also not far from it. The presentation of result in the world Congress like a advertising and give hope to many AD patients. Investment in GenB need holding power.
Folks at TauRX have the up to date news…I wonder if there is activity within the privately held shares of TauRX which would be the real indicator…if there is no sales means the investors are positive of the outcome and are holding to realise when the company is listed or taken over by big Pharma company.
More and more research i conduct on TauRX I am pretty confident approval will be given either by MHRA or FDA or both within 5- 6 months of providing final data which I assume is sometime this year probably Jan or February which suggests any time between July and September 2024. There are risks of course particularly due to Placebo, issue ..but not all drugs use an placebo. 2nd half results are due in August and run up to this will be very interesting time I reckon.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Ytl2023
332 posts
Posted by Ytl2023 > 2024-03-20 16:00 | Report Abuse
Going to limit how many times up if approve